Publications by authors named "C Mansat"

Article Synopsis
  • Metachromatic leukodystrophy (MLD) is a rare disease that affects the nervous system and is caused by a missing enzyme, leading to brain damage.
  • There are different types of MLD, and the most severe ones show symptoms early in life, causing serious problems and often leading to early death.
  • Researchers are testing a new treatment using gene therapy to help patients, and early results in mice show it can improve brain health and reduce damage, suggesting it might work for people too.
View Article and Find Full Text PDF

Results are reported from an absence of physiotherapic, orthopaedic, or surgical treatment in 31 cases of osteochondritis dissecans in 24 children. The mean age at diagnosis was 11 years and 4 months, and all the children were suffering from pain for an average of 3 months. None of these children were treated, except for instructions to discontinue involvement in sports activities until their pain had disappeared.

View Article and Find Full Text PDF

Methanolic extracts prepared from the leaves of Lantana camara have been found to inhibit human thrombin. An assay, in which thrombin activity is measured as a function of clot formation from fibrinogen, was used to guide the fractionation and purification of five principal active constituents (1-5), which were all characterized as 5,5-trans-fused cyclic lactone-containing euphane triterpenes.

View Article and Find Full Text PDF

A double blind randomized trial comparing subcutaneous enoxaparin (40 mg once daily) with standard unfractionated calcium heparin administered at a dose of 5,000 units every 8 hours in patients undergoing elective hip replacement has been performed. Treatment regimens began 12 hours preoperatively with enoxaparin, 2 hours preoperatively with standard unfractionated calcium heparin, and were continued for 15 days or until discharge. Venography was performed in all patients.

View Article and Find Full Text PDF

237 patients with a non-traumatic disease of the hip requiring total hip replacement entered a multicentre trial. Treatments were allocated at random in a double-blind manner: 113 patients received 5000 IU of standard heparin t.d.

View Article and Find Full Text PDF